BARBOUR, Andrew B., KIRSTE, Simon, GROSU, Anca-Ligia, SIVA, Shankar, LOUIE, Alexander V., ONISHI, Hiroshi, SWAMINATH, Anand, TEH, Bin S., PSUTKA, Sarah P., WEG, Emily S., CHEN, Jonathan, ZENG, Jing, GORE, John L., HALL, Evan, LIAO, Jay J., CORREA, Rohann J. M. and LO, Simon S., 2023. The judicious use of stereotactic ablative radiotherapy in the primary management of localized renal cell carcinoma. Freiburg: Universität.
Elsevier - Harvard (with titles)Barbour, A.B., Kirste, S., Grosu, A.-L., Siva, S., Louie, A.V., Onishi, H., Swaminath, A., Teh, B.S., Psutka, S.P., Weg, E.S., Chen, J., Zeng, J., Gore, J.L., Hall, E., Liao, J.J., Correa, R.J.M., Lo, S.S., 2023. The judicious use of stereotactic ablative radiotherapy in the primary management of localized renal cell carcinoma. Universität, Freiburg. https://doi.org/10.3390/cancers15143672
American Psychological Association 7th editionBarbour, A. B., Kirste, S., Grosu, A.-L., Siva, S., Louie, A. V., Onishi, H., Swaminath, A., Teh, B. S., Psutka, S. P., Weg, E. S., Chen, J., Zeng, J., Gore, J. L., Hall, E., Liao, J. J., Correa, R. J. M., & Lo, S. S. (ca. 2023). The judicious use of stereotactic ablative radiotherapy in the primary management of localized renal cell carcinoma [Cd]. Universität. https://doi.org/10.3390/cancers15143672
Springer - Basic (author-date)Barbour AB, Kirste S, Grosu A-L, Siva S, Louie AV, Onishi H, Swaminath A, Teh BS, Psutka SP, Weg ES, Chen J, Zeng J, Gore JL, Hall E, Liao JJ, Correa RJM, Lo SS (2023) The judicious use of stereotactic ablative radiotherapy in the primary management of localized renal cell carcinoma. Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Barbour, Andrew B./ Kirste, Simon/ Grosu, Anca-Ligia/ Siva, Shankar/ Louie, Alexander V./ Onishi, Hiroshi/ Swaminath, Anand/ Teh, Bin S./ Psutka, Sarah P./ Weg, Emily S./ Chen, Jonathan/ Zeng, Jing/ Gore, John L./ Hall, Evan/ Liao, Jay J./ Correa, Rohann J. M./ Lo, Simon S., The judicious use of stereotactic ablative radiotherapy in the primary management of localized renal cell carcinoma, Freiburg 2023.